Cargando…
Better Late Than Never: The Impact of Steroidal Treatment on the Outcome of Melanoma Patients Treated with Immunotherapy
SIMPLE SUMMARY: In the era of immunotherapy, advanced melanoma patients have unprecedentedly higher survival rates. However, the application of immunotherapy may lead to immune-related adverse events (irAEs), which are often managed with steroids. The potential negative impact of steroids on the eff...
Autores principales: | Bar-Hai, Neta, Ben-Betzalel, Guy, Stoff, Ronen, Grynberg, Shirly, Schachter, Jacob, Shapira-Frommer, Ronnie, Asher, Nethanel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252883/ https://www.ncbi.nlm.nih.gov/pubmed/37297003 http://dx.doi.org/10.3390/cancers15113041 |
Ejemplares similares
-
Radiotherapy may augment response to immunotherapy in metastatic uveal melanoma patients
por: Grynberg, Shirly, et al.
Publicado: (2022) -
Efficacy and toxicity of Ipilimumab-Nivolumab combination therapy in elderly metastatic melanoma patients
por: Stoff, Ronen, et al.
Publicado: (2022) -
Real world evidence of Lenvatinib + anti PD-1 as an advanced line for metastatic melanoma
por: Stoff, Ronen, et al.
Publicado: (2023) -
Immunotherapy Discontinuation in Metastatic Melanoma: Lessons from Real-Life Clinical Experience
por: Asher, Nethanel, et al.
Publicado: (2021) -
Real World Outcomes of Ipilimumab and Nivolumab in Patients with Metastatic Melanoma
por: Asher, Nethanel, et al.
Publicado: (2020)